Fact CheckerSign in

NCT06217770Completed

Retrospective Study to Assess Real-Life Use of The Long Acting GnRH Agonist as Prostate Cancer Treatment

Retrospective, Non-interventional Study Assessing the Real-Life Use of The Long- Acting Gonadotropin-releasing Hormone Agonist as A Treatment for Locally Advanced or Meta-static Prostate Cancer in Hong Kong.

Source: ClinicalTrials.gov · Last updated 23 Jan 2024

Brief summary (registry, in English)

It is a retrospective review of the electronic medical record of patients on long-acting triptorelin in Hong Kong.

Status (registry)
Completed
Study type
Observational
Enrollment
237 (actual)
First submitted
11 Jan 2024
Start date
1 Apr 2023
Primary completion date
4 Jan 2024
Lead sponsor
Chinese University of Hong Kong
NCT number
NCT06217770

What you commit to

  • Study type: Observational
  • Participants enrolled: 237
  • From 1 Apr 2023 to the primary completion date, 4 Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Nil

Who the study is looking for

  • Patients of Chinese heritage
  • Prostate cancer patients with the following disease status:
    • High-risk prostate cancer having hormonal therapy as neoadjuvant / adjuvant treatment for prostatectomy or radiotherapy; or
    • Advanced / metastatic prostate cancer treated with long-term hormonal therapy; or
    • After primary therapy (surgery or radiotherapy) with biochemical recurrence; or
    • Castration-resistant prostate cancer status
  • Received at least one dose of 6-month Gonadotropin-releasing Hormone Agonist triptorelin formulation
  • Having at least 6 months of follow-up after administration of the 3-month to 6-month Gonadotropin-releasing Hormone Agonist triptorelin

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Prince of Wales Hospital
Coordinator of this site? Confirm its status
ShatinHong Kong SAR ChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.